Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

ClinicalTrials.gov ID: NCT03304379

Public ClinicalTrials.gov record NCT03304379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 12:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo And NSAID Controlled Study To Evaluate The Efficacy And Safety Of Fasinumab In Patients With Pain Due To Osteoarthritis Of The Knee Or Hip

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate the efficacy of fasinumab compared to placebo, when administered for up to 24 weeks in patients with pain due to osteoarthritis (OA) of the knee or hip. The secondary objectives of the study are: * To evaluate the efficacy of fasinumab compared to non-steroidal anti-inflammatory drugs (NSAID)s, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip * To assess the safety and tolerability of fasinumab compared to placebo and compared to NSAIDs, when administered for up to 24 weeks in patients with pain due to OA of the knee or hip

Study identification

NCT ID
NCT03304379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
1,650 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 26, 2017 (Actual)
Primary completion
Dec 13, 2019 (Actual)
Completion
Nov 9, 2020 (Actual)
Last update posted
Feb 24, 2023

2017 – 2020

United States locations

U.S. sites
71
U.S. states
27
U.S. cities
66
Facility City State ZIP Site status
Pinnacle Research Group, Llc Anniston Alabama 36207 —
Horizon Research Partners Mobile Alabama 36608 —
Clinical Research Advantage, Inc./Warner Family Practice, PC Chandler Arizona 85224 —
Synexus Central Phoenix Medical Clinic Phoenix Arizona 85020 —
Clinical Research Consortium Arizona Tempe Arizona 85283 —
Advance Research Center Anaheim California 92805 —
TriWest Research Associates, LLC El Cajon California 92020 —
Paragon Rx Clinical Research, Inc. Garden Grove California 92840 —
Catalina Research Institute, LLC Montclair California 91763 —
Sierra Clinical Research Roseville California 95661 —
UC Davis Center for Musculoskeletal Health Sacramento California 95817 —
Advanced Research Center, Inc San Diego California 92103 —
California Research Foundation San Diego California 92123 —
Paragon Rx Clinical Research, Inc Santa Ana California 92703 —
Encompass Clinical Research Spring Valley California 91978 —
Westlake Medical Research Thousand Oaks California 91360 —
Synexus Clinical Research US, Inc. Vista California 92083 —
Mountain View Clinical Research Denver Colorado 80209 —
New England Research Associates, LLC Bridgeport Connecticut 06606 —
CRM of Greater New Haven, LLC Hamden Connecticut 06157 —
Stamford Therapeutics Consortium Stamford Connecticut 06905 —
Avail Clinical Research, LLC DeLand Florida 32720 —
AMB Research Center, Inc Miami Florida 33144 —
Allied Biomedical Research Institute Miami Florida 33155 —
Lakes Research, LLC Miami Lakes Florida 33014 —
Bioclinica Research Orlando Florida 32806 —
Gulf Region Clinical Research institute Pensacola Florida 32514 —
Integral Rheumatology & Immunology Specialists (IRIS) Plantation Florida 33324 —
Progressive Medical Research Port Orange Florida 32127 —
Drug Studies America Marietta Georgia 30060 —
Georgia Institute For Clinical Research LLC Marietta Georgia 30060 —
North Georgia Clinical Research Woodstock Georgia 30189 —
Chicago Clinical Research Institute, Inc Chicago Illinois 60607 —
Affinity Clinical Research Institute Oak Lawn Illinois 60453 —
Clinical Research Advantage, Inc. Evansville Indiana 47714 —
MediSphere Medical Research Center, LLC Evansville Indiana 47714 —
L-MARC Research Center Louisville Kentucky 40213 —
Tandem Clinical Research Marrero Louisiana 70072 —
Tufts Medical Center, Inc. Boston Massachusetts 02111 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
Onyx Clinical Research Caro Michigan 48723 —
Synexus Clinical Research US, Inc. Richfield Minnesota 55423 —
Skyline Medical Center /Radiant Research, Inc. Elkhorn Nebraska 68022 —
Meridian Clinical Research Associates, LLC Omaha Nebraska 68134 —
Robert Kaplan, D.O. Las Vegas Nevada 89144 —
Amici Clinical Research, LLC Raritan New Jersey 08869 —
Albuquerque Clinical Trials, Inc. Albuquerque New Mexico 87102 —
Drug Trial Brooklyn Brooklyn New York 11230 —
Northwell Health Great Neck New York 11021 —
Drug Trials America Hartsdale New York 10530 —
Upstate Clinical Research Associates, LLC Williamsville New York 14221 —
Carolina Research Center Shelby North Carolina 28150 —
PMG Research of Wilmington LLC Wilmington North Carolina 28401 —
The Center For Clinical Research Winston-Salem North Carolina 27103 —
New Horizons Clinical Research Cincinnati Ohio 45242 —
Aventiv Research Inc Columbus Ohio 43213 —
DOC Clinical Research Dayton Ohio 45432 —
Center for Orthopaedics and Sports Medicine Indiana Pennsylvania 15701 —
Radiant Research, Inc. Anderson South Carolina 29621 —
Piedmont Comprehensive Pain Management Group Greenville South Carolina 29601 —
Radiant Research, Inc. Greer South Carolina 29651 —
Coastal Carolina Research Center at LowCountry Orthopaedics North Charleston South Carolina 29406 —
Piedmont Research Partners, LLC Old Point Station South Carolina 29707 —
ACME Research, LLC Orangeburg South Carolina 29118 —
Office of Dr.Ramesh C. Gupta MD Memphis Tennessee 38119 —
West Texas Clinical Research Lubbock Texas 79410 —
Clinical Investigations Of Texas Plano Texas 75075 —
Synexus USA Plano Texas 75093 —
Charlottesville Medical Research Center LLC Charlottesville Virginia 22911 —
Health Research of Hampton Roads, Inc Newport News Virginia 23606 —
Spokane Joint Replacement Center Spokane Washington 99218 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03304379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 24, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03304379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →